Epstein-Barr virus miR-BART6-3p inhibits the RIG-I pathway

Y Lu, Z Qin, J Wang, X Zheng, J Lu, X Zhang… - Journal of innate …, 2017 - karger.com
Recognition of viral pathogen-associated molecular patterns by pattern recognition
receptors (PRRs) is the first step in the initiation of a host innate immune response. As a …

Extracellular vesicles: novel vehicles in herpesvirus infection

L Liu, Q Zhou, Y Xie, L Zuo, F Zhu, J Lu - Virologica Sinica, 2017 - Springer
Herpesviruses are remarkable pathogens that have evolved multiple mechanisms to evade
host immunity, ensuring their proliferation and egress. Among these mechanisms …

RNA m6A methylation regulates virus–host interaction and EBNA2 expression during Epstein–Barr virus infection

X Zheng, J Wang, X Zhang, Y Fu… - Immunity …, 2021 - Wiley Online Library
Abstract Introduction N6‐methyladenosine (m6A) is the most prevalent modification that
occurs in messenger RNA (mRNA), affecting mRNA splicing, translation, and stability. This …

RETRACTED ARTICLE: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in …

LL Zuo, J Zhang, LZ Liu, Q Zhou, SJ Du, SY Xin… - Oncogenesis, 2017 - nature.com
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy, which is notorious among
head-and-neck cancers with its metastatic feature. Epstein–Barr virus (EBV) infection plays a …

[HTML][HTML] Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges

FG Sugiokto, R Li - Viruses, 2025 - mdpi.com
As a ubiquitous human pathogen, the Epstein–Barr virus (EBV) has established lifelong
persistent infection in about 95% of the adult population. The EBV infection is associated …

IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis

W Dang, P Cao, Q Yan, L Yang, Y Wang, J Yang, S Xin… - Cancer letters, 2021 - Elsevier
Epstein-Barr virus (EBV) is closely related to the development of several malignancies, such
as B-cell lymphoma (B-CL), by the mechanism through which these malignancies develop …

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma

L Liu, L Zuo, J Yang, S Xin, J Zhang, J Zhou… - Cancer …, 2019 - Wiley Online Library
Exosomes have emerged as novel vehicles for proteins and other contents in cancer
progression. Cyclophilin A (CYPA) is a pivotal member of immunophilin family. Whether …

Targeting exosomal EBV-LMP1 transfer and miR-203 expression via the NF-κB pathway: the therapeutic role of aspirin in NPC

L Zuo, Y Xie, J Tang, S Xin, L Liu, S Zhang… - … Therapy-Nucleic Acids, 2019 - cell.com
Nasopharyngeal carcinoma (NPC) is an invasive head-and-neck tumor with Epstein-Barr
virus (EBV) as an important etiological cause. The EBV oncoprotein Latent membrane …

Epstein-Barr virus synergizes with BRD7 to conquer c-Myc-mediated viral latency maintenance via chromatin remodeling

S Li, L Yang, Y Li, W Yue, S Xin, J Li, S Long… - Microbiology …, 2023 - Am Soc Microbiol
Epstein-Barr virus (EBV) switches between latent and lytic phases in hosts, which is
important in the development of related diseases. However, the underlying mechanism of …

An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model

C Wang, J Chen, J Li, Z Xu, L Huang… - The Journal of …, 2024 - Am Soc Clin Investig
Adoptive transfer of T cell receptor–engineered T cells (TCR-T) is a promising strategy for
immunotherapy against solid tumors. However, the potential of CD4+ T cells in mediating …